Cryz S J
Swiss Serum and Vaccine Institute, Bern.
Experientia. 1991 Feb 15;47(2):146-51. doi: 10.1007/BF01945415.
Advances in molecular biology have allowed for the identification of potential vaccine candidates against several parasitic diseases. Antigens from various life stages of Plasmodium and Schistosoma species and filarial worms have been cloned, sequenced and tested as vaccines. Results to date in animal models have been promising. Modest levels of protection against experimental human malaria have been obtained using both sporozoite and blood-stage antigens. However, a greater understanding of the mechanisms which lead to immunity against parasites is required before effective vaccines can be developed.
分子生物学的进展使得人们能够识别出针对几种寄生虫病的潜在疫苗候选物。疟原虫、血吸虫和丝虫不同生活阶段的抗原已被克隆、测序并作为疫苗进行测试。迄今为止,在动物模型中的结果很有前景。使用子孢子抗原和血液阶段抗原都已获得了对实验性人类疟疾的一定程度的保护。然而,在开发出有效的疫苗之前,需要更深入地了解导致针对寄生虫产生免疫的机制。